STI571 Plus Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Acute Lymphocytic Leukemia

NCT00015860 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: daunorubicin hydrochloride
DRUG: imatinib mesylate
DRUG: prednisone
DRUG: vincristine sulfate

Sponsor

Jonsson Comprehensive Cancer Center

Collaborators

[object Object]